Nalaganje...
777. Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy (OPAT)
BACKGROUND: While OPAT is known to be a safe, effective, and convenient treatment strategy for patients receiving intravenous antimicrobials in the outpatient setting, the risk of adverse events (AEs) increases when high-risk medications, such as liposomal amphotericin B (L-AMB), are utilized. There...
Shranjeno v:
| izdano v: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811176/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.845 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|